Clinical trial

A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer

NCT07783282

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record fezolinetant Normalized identity: fezolinetantView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record enzalutamide Normalized identity: enzalutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record apalutamide Normalized identity: apalutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record bicalutamide Normalized identity: bicalutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention GnRH agonist/antagonist Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-31

PhasePHASE1

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

fezolinetantDRUG · verified · RxNorm: fezolinetant

enzalutamideDRUG · verified · RxNorm: enzalutamide

apalutamideDRUG · verified · RxNorm: apalutamide

bicalutamideDRUG · verified · RxNorm: bicalutamide

GnRH agonist/antagonistDRUG

Sponsors & collaborators

Astellas Pharma Global Development, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07783282 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.